Genetics Generation Advancement Corp. (4160.TWO)

TWD 54.2

(3.83%)

Net Income Summary of Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp.'s latest annual net income in 2023 was 28.56 Million TWD , up 11.01% from previous year.
Genetics Generation Advancement Corp.'s latest quarterly net income in 2024 Q2 was 18.18 Million TWD , up 27.89% from previous quarter.
Genetics Generation Advancement Corp. reported an annual net income of 25.73 Million TWD in 2022, up 228.24% from previous year.
Genetics Generation Advancement Corp. reported an annual net income of 7.83 Million TWD in 2021, up 149.91% from previous year.
Genetics Generation Advancement Corp. reported a quarterly net income of 14.21 Million TWD for 2024 Q1, up 106.76% from previous quarter.
Genetics Generation Advancement Corp. reported a quarterly net income of 6.87 Million TWD for 2023 Q4, up 40.89% from previous quarter.

Annual Net Income Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Net Income of Genetics Generation Advancement Corp. (2023 - 2019)

Year	Net Income	Net Income Growth
2023	28.56 Million TWD	11.01%
2022	25.73 Million TWD	228.24%
2021	7.83 Million TWD	149.91%
2020	-15.7 Million TWD	-185.8%
2019	18.3 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	18.18 Million TWD	27.89%
2024 Q1	14.21 Million TWD	106.76%
2023 Q4	6.87 Million TWD	40.89%
2023 FY	28.56 Million TWD	11.01%
2023 Q3	4.88 Million TWD	-47.56%
2023 Q2	9.3 Million TWD	24.09%
2023 Q1	7.5 Million TWD	19.09%
2022 FY	25.73 Million TWD	228.24%
2022 Q4	6.29 Million TWD	0.0%
2021 FY	7.83 Million TWD	149.91%
2020 FY	-15.7 Million TWD	0.0%

Peer Net Income Comparison of Genetics Generation Advancement Corp.

Name	Net Income	Net Income Difference
BIONET Corp.	78.39 Million TWD	63.565%
DIVA Laboratories, Ltd.	73.61 Million TWD	61.198%
Welgene Biotech Co.,Ltd.	-2.64 Million TWD	1178.739%
Puriblood Medical Co., Ltd.	-51.59 Million TWD	155.364%
TFBS Bioscience Inc.	4.9 Million TWD	-481.89%